KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Non Operating Income: 2018-2019

Historic Non Operating Income for Castle Biosciences (CSTL) over the last 2 years, with Dec 2019 value amounting to -$2.9 million.

  • Castle Biosciences' Non Operating Income was N/A to $48,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.9 million, marking a year-over-year change of. This contributed to the annual value of -$2.9 million for FY2019, which is 978.31% down from last year.
  • As of FY2019, Castle Biosciences' Non Operating Income stood at -$2.9 million, which was down 978.31% from -$272,000 recorded in FY2018.
  • Over the past 5 years, Castle Biosciences' Non Operating Income peaked at -$272,000 during FY2018, and registered a low of -$2.9 million during FY2019.
  • Its 2-year average for Non Operating Income is -$1.6 million, with a median of -$1.6 million in 2018.
  • Data for Castle Biosciences' Non Operating Income shows a maximum YoY tumbled of 978.31% (in 2019) over the last 5 years.
  • Castle Biosciences' Non Operating Income (Yearly) stood at -$272,000 in 2018, then tumbled by 978.31% to -$2.9 million in 2019.